Skip Navigation

News & Events

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

2005 Vaccine Research Seminars

Future Seminars | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Seminars are held on the NIH campus in Building 40, Conference Rooms 1201 & 1203, on Tuesdays at 4:00 PM (except as noted).

Date

Name

Institution

Seminar

Dec. 13, 2005 Ripley Ballou Glaxo-Smith-Kline Malaria Vaccine Update
Nov. 29, 2005 Abe Pinter Public Health Research Institute, ICPH Examining the Role of gp120 Variable Region Domains in HIV neutralization and Vaccine Development
Nov. 8, 2005 Kanta Subbarao NIAID / NIH Live Attenuated Vaccines Against Influenza A H5N1 Viruses
Nov. 1, 2005 David Montefiori Duke University Judging Neutralizing Antibody-based HIV-1 Vaccine Immunogens: What is a Relevant Response?
Oct. 11, 2005 Jim Cunningham Harvard University Cysteine Proteases: Essential Host Factors for Ebola Virus Infection
Sept. 27, 2005 Gary Nabel VRC / NIH Vector and Immunogen Design for AIDS Vaccines: Progress and Challenges
June 7, 2005 Jim Crowe Vanderbilt University Genetic and structural bais for low affinity antiviral B cell responses in infancy.
June 1, 2005 Franz Heinz Med Univ of Vienna Structure and functions of the flavivirus envelope glycoprotein
May 16, 2005 Ian Wilson Scripps Institute Structural insights on virulence,neutralization and vaccine design for HIV-1 and 1918 influenza virus
May 10, 2005 Gunilla Karlsson Karolinska Targeting of innate immune pathways by alphavirus replicon vaccines
May 5, 2005 Crystal Mackall NCI / NIH Modulating immune responses with IL7
Apr. 26, 2005 Dennis Kasper Harvard University Relationship between an immunomodulatory molecule from symbiotic bacteria and the host immune system
Apr. 5, 2005 Mario Roederer VRC / NIH Multifactorial analysis of immune responses: What really happens during acute SIV infection?
Mar. 29, 2005 Tom Monath Acambis, Inc Novel live attenuated vaccines utilizing yellow fever 17D as a vector
Mar. 15, 2005 Rafick Sekaly University of Montreal HIV specific memory T cells: Death, renewal, & survival
Mar. 8, 2005 Marian Neutra Harvard University Viruses, epithelial cells and antibodies: mechanisms of mucosal transmission and mucosal protection
Mar. 1, 2005 Garry Nolan Stanford University Single cell phospho-proteomics of disease: signaling networks on a patient by patient basis
Feb. 15, 2005 Bruce Walker Harvard University Immune selection pressure and viral evolution in HIV infection
Feb. 1, 2005 Mike Lenardo NIAID / NIH Genetic dissection of the cytopathic effect of HIV-1
Jan. 18, 2005 Barry Rouse University of Tennessee TRegs, Virus Infections, and Vaccines

View Past Seminars

back to top

Last Updated January 25, 2012